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Background: There is increasing evidence that cell elastic properties should change consider-
ably in response to chemical agents affecting the physiological state of the endothelium. In this 
work, a novel assay for testing prospective endothelium-targeted agents in vitro is presented.
Materials and methods: The proposed methodology is based on nanoindentation spec-
troscopy using an atomic force microscope tip, which allows for quantitative evaluation of 
cell stiffness. As an example, we chose a pyridine derivative, 1-methylnicotinamide chloride 
(MNA), known to have antithrombotic and anti-inflammatory properties, as reported in recent 
in vivo experiments.
Results: First, we determined a concentration range of MNA in which physiological  parameters 
of the endothelial cells in vitro are not affected. Then, cell dysfunction was induced by  incubation 
with tumor necrosis factor-alpha (TNF-α) and the cellular response to MNA treatment after 
TNF-α incubation was studied. In parallel to the nanoindentation spectroscopy, the endothelium 
phenotype was characterized using a fluorescence spectroscopy with F-actin labeling, and bio-




Conclusion: We found that MNA could reverse the dysfunction of the endothelium caused by 
inflammation, if applied in the proper time and to the concentration scheme established in our 
investigations. A surprisingly close correlation was found between effective Young’s modulus 
of the cells and actin polymerization/depolymerization processes in the endothelium cortical 
cytoskeleton, as well as NO and PGI
2
 levels. These results allow us to construct the physiological 
model of sequential intracellular pathways activated in the endothelium by MNA.
Keywords: endothelium, cell stiffness, 1-methylnicotinamide chloride, atomic force  microscopy, 
nanomechanical sensing
Introduction
The structure and functional properties of the endothelium are integral in controlling 
various physiological processes in the human body, such as homeostasis, inflammation, 
leukocyte adhesion, or the control of vasomotor tone.1 Consequently, dysfunction of the 
endothelium can lead to many serious diseases that can affect a large number of people. 
Endothelial cells, similar to muscle or red blood cells, undergo constant squeezing 
and stretching from the environment due to their function and localization. Therefore, 
the elasticity of endothelial cells plays a key role in the maintenance of proper blood 
vessel flow, vascular pressure regulation, and other endogenous functions.1,2
In our recent work, an atomic force microscope (AFM) tip sensor was success-
fully used for characterization of the endothelium inflammatory state by means of 
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so-called nanoindentation spectroscopy.2 This novel experi-
mental  technique allows for quantitative determination of the 
mechanical properties at the single-cell level.2–4 Over the last 
decade, there have been several studies involving the use of 
AFM as an imaging tool and/or a mechanical nanosensor for 
characterization of endothelial cells.5–11 Kusche-Vihrog et al 
reported a significant increase of the human umbilical vein 
endothelial cell volume and surface area after the applica-
tion of aldosterone, which was associated with an increased 
expression of epithelial sodium channel and sodium trans-
port disturbance.5 On the other hand, the use of aldosterone 
antagonists – spironolactone and amiloride – reversed the 
effect of aldosterone. Oberleithner et al examined the impact 
of steroid hormones, such as estradiol and aldosterone, on 
the volume and stiffness of endothelial cells.6 Additionally, 
they found a striking relationship between stiffness and nitric 
oxide (NO) production by endothelial cells.10,11
The results mentioned above encouraged us to establish 
a working protocol to test the effect of endothelial active 
pharmaceutics on the mechanical properties at a single-cell 
level and determine the relationship between the cell elasticity 
parameter (effective Young’s modulus) and the physiological 
state of the endothelium. In our work, we used a prospective 
endothelial agent, 1-methylnicotinamide chloride (MNA), 
which is applied on the endothelial cells under different 
stages of the inflammatory process caused by tumor necrosis 
factor-alpha (TNF-α). MNA is a metabolite of nicotinamide, 
which is formed in the liver by nicotine N-methyltransferase. 
It was found by Gebicki et al12 and Wozniacka et al13 that 
topically applied MNA has a remarkable therapeutic effect on 
 several inflammatory skin diseases, including rosacea, acne 
vulgaris, skin burns, and wound healing. Later, Chlopicki et al14 
demonstrated the anti-inflammatory and antithrombotic 
potential of MNA in in vivo experiments.
The present work intends to verify whether the mechanical 
response of human dermal microvascular endothelial cells 
(HMECs) to incubation with MNA, as measured using nano-
indentation spectroscopy with an AFM tip, could be effectively 
used as a bioindicator of the physiological state of the cells. 
Therefore, we investigated the extent of the anti-inflammatory 
effect of MNA on the early stage of inflammation triggered 
by incubation with TNF-α for 1 hour. Using F-actin staining 
for optical fluorescence microscopy we could demonstrate 
that the elasticity changes of the cells are connected to the 
actin cytoskeleton  rearrangement. Additional information on 
the molecular mechanism of MNA action on endothelium 
is provided by performing measurements of NO and pros-
tacyclin (PGI
2
) production. The close correlation between 
the fluorescence microscopy results, the data obtained with 
the biochemical methods, and the elasticity measurements 
demonstrate that the effective elasticity modulus could be suc-
cessfully used for diagnostics of the endothelium phenotype 
in an in vitro model. The application of the nanoindentation 




HMECs were obtained from the Centers for Disease  Control 
and Prevention (Atlanta, GA, USA). L-glutamine, fetal 
bovine serum, human epidermal growth factor, and antibiot-
ics used (penicillin, streptomycin, fugison) were purchased 
from Invitrogen (Life Technologies, Carlsbad, CA, USA). 
The MCDB medium, Dulbecco’s Phosphate-Buffered Saline 
(DPBS 1X pH 7.4), trypsin (0.25%), hydrocortisone, and 
TNF-α were purchased from Sigma-Aldrich (St Louis, 
MO, USA). MNA in the form of 1-methylnicotinamide 
chloride was kindly provided by Professor Jerzy Gebicki, 
Lodz University of Technology (Lodz, Poland). The cell 
culturing method for HMECs was as previously described.8 
MCDB medium supplemented with 10% serum, 1% 
L-glutamine, 2% hydrocortisone, 0.001% epidermal growth 
factor, and 0.1% antibiotics (penicillin, streptomycin, and 
fungisan) was used. Cells were seeded on the culture flasks 
and incubated for 3 days at 37°C, followed by rinsing with 
DPBS (pH 7.4). Briefly, the cells were trypsinized at 37°C 
to detach the adherent cells from the flask until most of the 
cells were collected. Next, 2 mL serum and 5 mL MCDB 
medium were added to the flask to neutralize the trypsin. The 
prepared solution was then transferred to a 15 mL sterile cen-
trifuge tube for centrifugation at 1200 rpm for 5 minutes and 
resuspended in fresh growth medium. All of the solvents used 
were laboratory (suitable for general laboratory applications) 
and American Chemical Society (high-quality) grade. Each 
product was used without any additional purification.
Preparation of samples
Poly-L-lysine glass plates (1 cm × 1 cm) were rinsed with etha-
nol and sterilized with ultraviolet light in a laminar chamber for 
30 minutes. Then, HMECs from the fourth to seventh passage 
were seeded on the plates at a concentration of 105 cells/mL 
for 48 hours in a 5% CO
2
 atmosphere at 37°C.
The inflammatory effect of TNF-α on HMECs was care-
fully investigated in our previous work.2 The current study 
took advantage of the previous investigation by exposing the 
cells to a TNF-α concentration of 10 ng/mL for additional 
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incubation periods (0.5, 2, 4, and 20 hours, while previously 
the results were published for 1, 3, 6, 12, and 24 hours) to 
clearly determine the strong inflammatory phase triggered 
by TNF-α. For each incubation period, a cytokine-unexposed 
sample was prepared in parallel to the reference. TNF-α was 
dissolved in fresh medium to a final concentration of 10 ng/
mL. The loosely bound cells were removed from the substrate 
by rinsing with fresh medium heated to 37°C. In accordance 
with the previous results, the strongest inflammatory response 
was obtained following a 1-hour incubation with TNF-α; thus, 
this phase was chosen as an in vitro model of dysfunction by 
which to study the action of MNA. Prior to the investigation of 
the MNA anti-inflammatory potential, the effect of MNA alone 
on healthy cells was characterized to determine the appropriate 
concentration. Cells were directly exposed to MNA at concen-
trations of 0.1 µM and 10 µM for various incubation periods 
(1, 3, 6, 12, or 24 hours).  Elasticity measurements revealed that 
an MNA concentration of 0.1 µM was the most suitable (see 
“Results” section). Motivated by the latter observation, it was 
found necessary to investigate the anti-inflammatory action of 
MNA at concentrations of 0.1 µM, 0.2 µM, and 0.05 µM.
The cells were exposed to TNF-α for 1 hour and then 
incubated with MNA for various time periods (1, 3, 6, 12, or 
24 hours). The cells exposed to TNF-α only were used as a 
reference for the combined samples (TNF-α and MNA) for the 
corresponding incubation period. The elasticity, NO produc-
tion, and fluorescent staining of the actin cytoskeleton were 
investigated to determine the therapeutic behavior of MNA.
Elasticity measurements
Nanoindentation spectroscopy using an AFM tip is one of the 
most versatile techniques for the determination of mechanical 
properties at the nanometer scale. Elastic properties were char-
acterized with the use of a NanoScope IIIa MultimodeTM SPM 
(Veeco, Plainview, NY USA) with soft triangular cantilevers 
(MLCT multilever, spring constant approximately 0.01 N/m; 
Veeco). The tip radius and geometry were determined by scan-
ning a TGT1 (NT-MDT, Moscow, Russia) spike grid standard 
in contact mode and deconvoluted in SPIP software (SPIP 5; 
Image Metrology A/S, Hørsholm, Denmark). The spring con-
stant of all cantilevers used was calculated from the thermal 
oscillations of an unloaded lever in air15 and analyzed using 
the NanoScope 6.1 software (Veeco). Prior to measurements, a 
calibration curve was acquired on a pure glass plate immersed 
in medium. The samples were placed on a piezo scanner and 
measured without fixation inside a liquid cell in medium 
prewarmed to 37°C. First, the topography of the surface was 
recorded in AFM contact mode. Then, a 7 µm × 7 µm region 
(average size) was selected in the central part of the cell, and 
144 force–distance curves were collected on the rectangular 
grid of points. For each sample, at least six different cells 
were characterized. This study employed the Hertz–Sneddon 
model16 because it offers a reasonable fit to the acquired 
force–indentation curves. The elasticity parameter E (effective 
Young’s modulus) was calculated for every force–indentation 









3 2  (1)
where R is the tip radius and the Poisson ratio (ν) is 
assumed to be 0.5 (ie, isotropic elastic properties for small 
deformations).
The elasticity parameter reflects the cell stiffness, with a 
lower elasticity parameter indicating a softer cell. For each 
experimental point (ie, reference cells or cells incubated 
with investigated agent for a defined incubation period), 
cumulative histograms were prepared (see Supplementary 
material). Each histogram is based on all the cells analyzed 
for a given sample. Force–indentation curve data analysis 
was as described in our previous work.2
The relative change in the elasticity parameter (∆E) was 
calculated for all the experimental points for treated cells 
(TNF-α or MNA) compared to the control cells for the 
corresponding incubation period. By fitting the log-normal 
function, the relative changes in the elasticity parameter were 
calculated in comparison to the reference cells incubated on 
the glass for the same time period. In order to compare the 
data, ∆E is described by the following equation:
 ∆E E E
E






where Ei control_  and Ei agent_  are the median values of the 
elasticity parameter E for control cells and cells incubated 
with agents, respectively.
The distribution of the data within each group was tested 
against log-normal distribution using the Kolmogorov–
Smirnov test at the level P = 0.05. Additionally, the statistical 
analysis of the data was performed using analysis of variance 
to determine differences between means for each group and 
the control group at the levels P , 0.05 and P , 0.01.
Fluorescence microscopy
Fluorescence microscopic images play a key role in 
 studying the cytoskeletons of cells. They provide us with 
detailed  information about the F-actin and globular G-actin 
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 (monomeric subunits) content of the microfilaments. 
The change in the F-actin content results in the modification 
of the elastic properties, typically followed by the modifica-
tion of the cell shape. Fluorescence microscopy provides 
support for observations based on the results of elasticity 
 measurements. To visualize the cytoskeletal reorganization 
triggered by TNF-α or MNA, F-actin fibers were stained with 
Alexa Fluor 488 (green). The fluorescent stains  (phallotoxine, 
Alexa Fluor 488 phalloidin) were purchased from Invitro-
gen  (Warsaw, Poland). The poly-L-lysine glass slides were 
obtained from Thermo Fisher Scientific (Waltham, MA, 
USA).
Prior to staining, the cells were rinsed with warm 
phosphate-buffered solution (PBS). The cells were fixed for 
10 minutes in 2% formaldehyde in a PBS solution, rinsed 
two times with PBS, permeabilized for 4 minutes in 0.1% 
Triton X (Sigma-Aldrich) and rinsed twice more with PBS. 
The cells were then incubated with PBS and 1% bovine serum 
albumin (BSA). Next, Alexa Fluor 488 (10 µL/500 µL PBS) 
was used to stain the F-actin fibers for 16 minutes at room 
temperature. Following staining, the excess dye was removed 
by rinsing two times with PBS.
The stained cell samples were prepared for fluorescence 
imaging and excited with an Olympus X-Cite Q120 lamp 
(Olympus Corporation, Tokyo, Japan). They were transmitted 
by U-MWIB2 (phallotoxine) filters and visualized through 
an Olympus IX71 with a 20× objective. The images were 
recorded and then processed using Olympus CellSense 
software (version 1.41).
Griess method
The endothelium actively participates in, and is an important 
organ affected by, the systemic inflammatory process. Under 
the influence of an inflammatory agent, endothelial functions 
reorganize to increase inflammatory mediator secretion 
and the activity of adhesion molecules. The proinflamma-
tory response of the endothelium is closely associated with 
changes in the production of vasoprotective mediators, such 
as NO. NO is an unstable molecule that is quickly metabo-
lized into the more stable compounds nitrite (NO2
−) and nitrate 
(NO3
−). The initial concentration of NO can be indirectly 
measured by determining the concentrations of nitrite and 
nitrate.17 Briefly, 100 µL of solution was obtained from the 
supernatants of the HMEC culture and incubated with an 
equal volume of Griess reagent (0.35% 4-4-aminophenyl 
sulfone, 0.1% N-(1-naphthyl) ethylenediamine dihydro-
chloride in 1 M hydrochloric acid) at room temperature for 
10 minutes. The absorbance at 550 nm was measured, and 
the nitrite concentration was calculated from a sodium nitrite 
standard curve.17 The percentage changes in the production of 
NO following TNF-α exposure with regard to the respective 
control samples were calculated.
PGI2 production measurements
The measurement of PGI
2
 release is a standard method for 
the evaluation of the physiological state of the endothelium. 
In vivo, it is typically measured using blood samples through 
the absorbance measurement of 6-keto-prostaglandin F1α 
(PGF1α), which is the direct metabolite of PGI
2
. For the 
quantitative analysis of 6-keto-PGF1α, we investigated with 
the enzyme-linked immunosorbent assay method. In the 
presented work, the PGI
2
 level provides information about 
the activated intracellular pathways. The in vitro release of 
PGI
2
 was estimated by collecting the supernatants of HMECs 
cultured in controlled conditions.
Samples incubated with TNF-α only, MNA only, and com-
bination of MNA and TNF-α were investigated.  Supernatants 
were assayed directly using an EIA Kit (Enzo Life Sciences, 
Warsaw, Poland). The supernatants were then acidified with 
0.1 M hydrogen chloride and incubated for 15 minutes at 
4°C. After centrifugation, the liquid phase was applied on a 
C
18
 reverse phase extraction column, previously washed with 
10 mL ethanol followed by 10 mL deionized water. Later, the 
column was washed sequentially with 10 mL water, 10 mL 
15% ethanol, and 10 mL hexane. Finally, the sample was 
eluted from the column by the addition of 10 mL ethyl acetate. 
Next, the sample was dried in the nitrogen stream and 250 µL 
of assay buffer was added. The sample was then mixed by 
vortex for 5 minutes at room temperature.
Results and discussion
Cell elasticity changes indicate the 
physiological state of the endothelium
Characterization of the effect of varying MNA 
concentrations
Firstly, the relative changes of the elasticity parameter are 
used for determination of the appropriate range of concentra-
tions at which the effect of MNA alone does not change the 
endothelial cell functional properties in a noticeable way. 
The median values of the elasticity parameters determined 
from their cumulative distributions are presented in Figure 1. 
Additionally, F-actin staining fluorescence images for vari-
ous incubation periods with two selected concentrations of 
MNA are presented in Figure 2.
Endothelial cells incubated with 10 µM MNA show a 
relatively high increase in the elasticity parameter for longer 
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periods of incubation (12, 24 hours). These results are in agree-
ment with the optical fluorescence features characteristics for 
actin cytoskeleton reorganization (Figure 2D and E). Exposing 
the endothelium to MNA at the higher concentration causes 
polymerization of the G-actin, and strong, clearly visible, 
parallel F-actin fibers are present. On the other hand, lower-
ing the concentration of MNA by two orders of magnitude 
(0.1 µM) results in only slight fluctuations of the elasticity 
parameter, mostly at the level just below the reference. The 
latter observation is confirmed by a decrease in the F-actin 
content (Figure 2B and C). It is clear, therefore, that the 
incubation of endothelial cells with 0.1 µM of MNA does not 
induce any visible changes in the phenotype of the cells. On the 
other hand, the fluorescent staining of the F-actin distribution 
reveals a minor depolymerization of fibers in comparison to the 
reference sample. Hence, the 0.1 µM concentration of MNA 
is selected for further investigation of its anti-inflammatory 
potential. Additionally, further characterization of the dose 
dependence is performed in the following section on MNA, 
ie, the concentrations of 0.05 µM and 0.2 µM are used.
Effect of MNA against inflammation in the endothelium
In our previous work,2 the in vitro inflammatory model was 
established based on TNF-α proinflammatory cytokine. 
It was found that incubation of endothelial cells with the 
cytokine results in a two-stage response, as revealed by 
the changes in cell elasticity (Figure 3A). The strongest 
inflammatory phase is observed 1 hour after the applica-
tion of TNF-α, and hence it was chosen for the study of 
the anti-inflammatory potential of MNA. In Figure 3, the 
relative elasticity parameter changes of the cells sensitized 
with TNF-α for 1 hour and subsequently incubated for 1, 3, 
6, 12, and 24 hours with different concentrations of MNA 
are presented (0.05 µM [Figure 3B], 0.1 µM [Figure 3C], 
0.2 µM [Figure 3D]). For the lowest concentration of MNA 
(0.05 µM), the inflammatory response of the cells is visible 
0.0









































Figure 1 Comparison of the elasticity parameter for two concentrations of MNA.
Notes: An increased elasticity parameter at 12 and 24 hours (h) was observed for 
10 µM of MNA. The statistically significant differences from the native samples are 
*P , 0.05 and **P , 0.01.






Figure 2 Fluorescent microscopy cell images showing the differences in the thickness and distribution of F-actin fibers in different MNA incubations.
Notes: (A) Unexposed cells; (B) 0.1 µM (12 hours); (C) 0.1 µM (24 hours); (D) 10 µM (12 hours); (E) 10 µM (24 hours). Arrows indicate the polymerized parallel F-actin 
fibers. Scale bars: 50 µm.
Abbreviations: F-actin, filamentous actin; MNA, 1-methylnicotinamide chloride.
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Figure 3 The relative changes of cell elasticity parameter.
Notes: (A) Cells incubated with TNF-α for various periods (gray bars); (B–D) cells incubated with TNF-α (1 hour) followed by MNA (1, 3, 6, 12, and 24 hours (h); blue bars) 
at different MNA concentrations (0.05 µM, 0.1 µM, and 0.2 µM, respectively). The statistically significant differences from the native samples are *P , 0.05 and **P , 0.01.




Figure 4 Fluorescent microscopy images.
Notes: (A) Reference; (B) MNA 3 hours; (C) TNF-α 4 hours; (D) TNF-α 
1 hour + MNA 3 hours. Arrow 1 indicates strong fibers, reflecting the polymerization 
of G-actin; arrow 2 indicates the reference-like cells; and arrow 3 indicates the single 
F-actin fibers. Scale bars: 20 µm.
Abbreviations: G-actin, globular actin; TNF-α, tumor necrosis factor-alpha; MNA, 
1-methylnicotinamide chloride; F-actin, filamentous actin.
only up to 6 hours. Longer incubation periods reveal the 
elasticity of cells close to the reference level. Increasing 
the drug concentration twice (0.1 µM) resulted in a drop in 
elasticity after 1 hour incubation in relation to the cytokine 
effect, the reversion of TNF-α influence after 3 hours, and 
no further changes in relation to the native cells after longer 
incubation periods. In contrast, the highest concentration of 
MNA (0.2 µM) revealed dramatic changes in the elasticity of 
the cells. Three and 6 hours after the application of the drug, 
the elasticity dropped significantly, reverted to the reference 
level for 12 hours and later increased again for 24 hours. The 
study has demonstrated the anti-inflammatory response for 
lower concentrations of the drug (0.05 µM, 0.1 µM). Interest-
ingly, 3 hours of MNA (0.1 µM) exposure seems to be crucial, 
since at this time point, a considerable effect of MNA as an 
anti-inflammatory agent is acquired.
Based on the observations that the changes in the elastic-
ity parameter are directly connected with the reorganization 
of the actin cytoskeleton, the fluorescent staining of F-actin 
fibers was performed. The results presented in Figure 4 
depict the F-actin distribution for reference endothelial cells 
(Figure 4A) and the cells incubated with 0.1 µM of MNA 
for 3 hours (Figure 4B). It can be seen that MNA induces 
slight depolymerization of the F-actin in comparison to the 
reference cells. The inflammatory state of the endothelial 
cells (Figure 4C) is characterized by the presence of short, 
thick, nonparallel fibers located in the central part of the cell, 
which is caused by the polymerization of G-actin (Figure 4C). 
Therefore, it is clear that the action of MNA (Figure 4D) 
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results in the depolymerization of F-actin fibers in relation 
to the inflamed cells, and only single short fibers are vis-
ible. This corresponds with relative changes of the elasticity 
parameter presented in Figure 3C. On the other hand, an 
increase in the G-actin content contributes to NO production 
in two ways. Firstly, the elevated level of G-actin increases 
the availability of binding sites for endothelial NO synthase 
(eNOS). Secondly, it stimulates the transport of L-arginine, 
which is the main substrate for NO synthesis.18,19
Correlations between elasticity changes 
and biochemical parameters in response 
to MNA
As stated in the previous sections, the response of endothe-
lial cells to MNA anti-inflammatory action leads to the 
attenuation of the elasticity parameter changes with respect to 
untreated endothelium. To further understand this effect, the 
elasticity measurements are supplemented with NO and PGI
2
 
release measurement. In Figure 5, the results obtained for the 
















Figure 6 The cycle of processes involved in the intracellular flow of Ca2+, NO, 
and PGI2.
Notes: The red rectangle indicates the components that might be directly influenced 
by MNA.
Abbreviations: AA, arachidonic acid; CaM, calmodulin; COX, cyclooxygenase; 
eNOS, endothelial nitric oxide (NO) synthase; ER, endoplasmic reticulum; F-actin, 
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Figure 5 Relative changes of elasticity parameter, NO production, and PGI2 release.
Notes: (A) Elasticity parameter (white-striped bars)/NO production (blue bars). (B) PGI2 release for selected incubation conditions: TNF-α (1 hour [h]); TNF-α (4 hours); 
and TNF-α (1 hour) + MNA (3 hours). The relative changes of NO production/PGI2 secretion were calculated compared to the control level (1.83 ± 0.4 µM)/(5.97 ± 0.84 ng/
mL) (mean ± SD). The statistically significant differences from the native samples are *P , 0.05 and **P , 0.01.
Abbreviations: TNF-α, tumor necrosis factor-alpha; MNA, 1-methylnicotinamide chloride; NO, nitric oxide; PGI2, prostacyclin; SD, standard deviation.
with TNF-α are compared with the cell response following 
a 3-hour MNA incubation of cells previously exposed to the 
cytokine for 1 hour, ie, for the same total incubation time. 
TNF-α applications for 1 and 4 hours result in a distinctive 
increase of the elasticity parameter, while incubation with 
MNA leads to a reduction of the elasticity parameter back to 
a value close to the reference level (Figure 5A). Furthermore, 
the inflammation caused by incubation with TNF-α leads 
to a significant reduction in NO production, which again 
approaches the reference level following the application of 
MNA for 3 hours (Figure 5A).
Furthermore, it can be seen in Figure 5B that TNF-α 
greatly reduces the secretion of PGI
2
 for 1 hour incubation 
time, whereas for 4 hours of incubation, a rather slight reduc-
tion of the secretion is observed. For cells incubated with 
TNF-α for 1 hour and then MNA for 3 hours, the PGI
2
 level 
is much higher than for the reference cells. These results 
confirm that the intracellular pathways induced by MNA are 
also connected to PGI
2
 and NO production by the cells.
Intracellular pathways activated by MNA
Our investigations demonstrate that MNA induces changes in 
the concentration of NO and PGI
2
. The results are  consistent 
with in vivo investigations by Chlopicki et al,14 who suggested 
that MNA elevates the concentration of arachidonic acid (AA), 
very likely through the activation of phospholipase A
2
, an 
enzyme located in the cellular membrane that releases AA from 
the membrane phospholipids. Based on these observations, we 
considered possible molecular pathways involved in the MNA 
action on endothelial cells, schematically shown in Figure 6. It 
is plausible that the increased level of AA initiates two intrinsic 
pathways leading to the stimulation of NO production, which is 
the marker of anti-inflammatory response. The first pathway is 
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connected with the metabolism of AA through the cyclooxyge-
nase to PGI
2
. This pathway, leading to an increase in the PGI
2
 
level, is consistent with the results presented in Figure 5B. 
The PGI
2
 directly activates eNOS, which synthesizes NO.20 
In the second pathway, AA directly opens calcium-permeable 
channels, resulting in an increase in Ca2+ levels.21 Calcium ions 
may create a complex with calmodulin, which binds to eNOS, 
inducing the NO production.22 Additionally, F-actin depolymer-
ization gives rise to the number of eNOS binding sites, which 
is constituted by the enhanced eNOS activity and elevates NO 
release.18 The application of MNA to inflamed endothelial cells, 
which present decreased levels of NO, activates the proposed 
pathways leading to the elevation in NO production up to the 
level of native cells, as shown in Figure 5A.
Conclusion
In this work, we demonstrated that cell elasticity could serve 
as a very sensitive bioindicator of the endothelium physiologi-
cal state. Since quantitative determination of the cell Young’s 
modulus has become possible by means of nanoindentation 
spectroscopy using an AFM tip, the  elasticity measurement 
could offer an alternative method for cell diagnostics and 
testing the cellular activity of various pharmacological agents. 
This conclusion has been verified by the case study performed 
with MNA, known to have anti-inflammatory properties in in 
vivo experiments. The study shows the dose-dependent MNA 
influence on the elasticity of the cells, confirmed by the F-actin 
labeling and fluorescence microscopy, as well as by analyzing 
changes in NO production and PGI
2
 release. Furthermore, we 
propose the physiological mechanism for this MNA activity, 
based on the biochemical cycle that involves NO and PGI
2
 
regulatory agents. This mechanism may explain the therapeu-
tic effects of MNA against inflammation of the endothelium 
in both in vitro and in vivo environments.
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Figure S1 Elasticity parameter (E) distributions for reference cells (A) and cells incubated with 10 µM of MNA for (B) 1 hour, (C) 3 hours, (D) 6 hours, (E) 12 hours and 
(F) 24 hours. Log-normal distribution (solid curves), resultant median values and its inaccuracies are presented.













































































Figure S2 Elasticity parameter (E) distributions for reference cells (A) and cells incubated with 0.1 µM of MNA for (B) 1 hour, (C) 3 hours, (D) 6 hours, (E) 12 hours and 
(F) 24 hours. Log-normal distribution (solid curves), resultant median values and its inaccuracies are presented.
Abbreviation: MNA, 1-methylnicotinamide chloride.
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Figure S3 Elasticity parameter (E) distributions for reference cells (A) and cells incubated with TNF-α (1 hour) plus 0.1 µM of MNA for (B) 1 hour, (C) 3 hours, (D) 6 hours, 
(E) 12 hours and (F) 24 hours. Log-normal distribution (solid curves), resultant median values and its inaccuracies are presented.












































































Figure S4 Elasticity parameter (E) distributions for reference cells (A) and cells incubated with TNF-α (1 hour) plus 0.2 µM of MNA for (B) 1 hour, (C) 3 hours, (D) 6 hours, 
(E) 12 hours and (F) 24 hours. Log-normal distribution (solid curves), resultant median values and its inaccuracies are presented.
Abbreviations: MNA, 1-methylnicotinamide chloride; TNF-α, tumor necrosis factor-alpha.
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Figure S5 Elasticity parameter (E) distributions for reference cells (A) and cells incubated with TNF-α (1 hour) plus 0.05 µM of MNA for (B) 1 hour, (C) 3 hours, (D) 
6 hours, (E) 12 hours and (F) 24 hours. Log-normal distribution (solid curves), resultant median values and its inaccuracies are presented.
Abbreviations: MNA, 1-methylnicotinamide chloride; TNF-α, tumor necrosis factor-alpha.











































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
